Hyperactivity, decreased startle reactivity, and disrupted prepulse inhibition following disinhibition of the rat ventral hippocampus by the GABAA receptor antagonist picrotoxin

Abstract.Rationale: Functional imaging studies have revealed overactivity of the hippocampus in schizophrenic patients. Neuropathological data indicate that hyperactivity of excitatory hippocampal afferents and decreased hippocampal GABA transmission contribute to this overactivity. In rats, excitation of the ventral hippocampus, e.g. by NMDA, results in hyperactivity and disruption of sensorimotor gating measured as prepulse inhibition (PPI) of the acoustic startle response, behavioral effects related to psychotic symptoms in humans. Objective: The present study examined whether disinhibition of the ventral hippocampus by the GABAA antagonist picrotoxin would result in similar psychosis-related behavioral disturbances (hyperactivity, decreased PPI) as NMDA stimulation. Methods and results: Wistar rats received bilateral infusions of subconvulsive doses of picrotoxin (100 or 150 ng/0.5 µl per side) into the ventral hippocampus and were then immediately tested for open field locomotor activity or startle reactivity and PPI. Only the higher dose induced hyperactivity and decreased PPI. Both doses decreased acoustic startle reactivity to a similar extent. The decreased PPI appeared not to result from decreased startle reactivity, but was associated with a diminished potency of the prepulses to inhibit the startle reaction to the startle pulse, indicating a sensorimotor gating deficit. All effects were temporary, i.e. disappeared when the rats were tested 24 h after infusion. Conclusions: Decreased GABAergic inhibition in the ventral hippocampus of rats yielded psychosis-related behavioral effects, very similar to those induced by NMDA stimulation. Thus, a concurrence of decreased GABAergic inhibition and increased afferent excitation in the hippocampus of schizophrenic patients might contribute to psychotic symptoms.

[1]  B. J. Winer Statistical Principles in Experimental Design , 1992 .

[2]  L. Nadel Dorsal and ventral hippocampal lesions and behavior , 1968 .

[3]  W. Cowan,et al.  An autoradiographic study of the organization of the efferet connections of the hippocampal formation in the rat , 1977, The Journal of comparative neurology.

[4]  M. Geyer,et al.  Prestimulus effects on human startle reflex in normals and schizophrenics. , 1978, Psychophysiology.

[5]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[6]  E. Cavalheiro,et al.  Injections of picrotoxin and bicuculline into the amygdaloid complex of the rat: An electroencephalographic, behavioural and morphological analysis , 1985, Neuroscience.

[7]  J. Ison,et al.  Effects of motor activity on the elicitation and modification of the startle reflex in rats , 1986 .

[8]  M. Witter,et al.  Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris leucoagglutinin , 1987, Neuroscience.

[9]  G. Mogenson,et al.  Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: An electrophysiological and behavioural study , 1987, Neuroscience.

[10]  J. Rawlins,et al.  The neuropsychology of schizophrenia , 1991, Behavioral and Brain Sciences.

[11]  I. Weiner,et al.  From an animal model of an attentional deficit towards new insights into the pathophysiology of schizophrenia. , 1992, Journal of psychiatric research.

[12]  N. Swerdlow,et al.  Hippocampal modulation of acoustic startle and prepulse inhibition in the rat , 1992, Pharmacology Biochemistry and Behavior.

[13]  D. Weinberger,et al.  Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat , 1992, Brain Research.

[14]  Karl J. Friston,et al.  Patterns of Cerebral Blood Flow in Schizophrenia , 1992, British Journal of Psychiatry.

[15]  C. Grillon,et al.  Startle gating deficits occur across prepulse intensities in schizophrenic patients , 1992, Biological Psychiatry.

[16]  Karl J. Friston,et al.  The left medial temporal region and schizophrenia. A PET study. , 1992, Brain : a journal of neurology.

[17]  H. Schnitzler,et al.  Acoustic startle response and habituation in freezing and nonfreezing rats. , 1993, Behavioral neuroscience.

[18]  N. Swerdlow,et al.  Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. , 1994, Archives of general psychiatry.

[19]  Peter Somogyi,et al.  Diverse sources of hippocampal unitary inhibitory postsynaptic potentials and the number of synaptic release sites , 1994, Nature.

[20]  David L. Braff,et al.  Information-processing deficits and thought disorder in schizophrenia. , 1994 .

[21]  P. Lang The emotion probe. Studies of motivation and attention. , 1995, The American psychologist.

[22]  S. Brudzyński,et al.  Mesolimbic dopamine terminals and locomotor activity induced from the subiculum , 1995, Neuroreport.

[23]  Julia Gray,et al.  A Model of the Limbic System and Basal Ganglia: Application to anxiety and schizophrenia , 1995 .

[24]  Richard S. J. Frackowiak,et al.  A functional neuroanatomy of hallucinations in schizophrenia , 1995, Nature.

[25]  H. Matsuda,et al.  Regional cerenral blood flow in patients with schizophrenia: relevance to symptom structures , 1996, Psychiatry Research: Neuroimaging.

[26]  T. Blumenthal,et al.  A relationship between inhibition of the acoustic startle response and the protection of prepulse processing , 1996, Psychobiology.

[27]  C. A. Morgan,et al.  Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[28]  Y. Kawasaki,et al.  Regional cerebral blood flow in patients with schizophrenia: Relevance to symptom structures , 1996, Schizophrenia Research.

[29]  N. Swerdlow,et al.  The ventral subiculum modulation of prepulse inhibition is not mediated via dopamine D2 or nucleus accumbens non-NMDA glutamate receptor activity. , 1996, European journal of pharmacology.

[30]  R. Kerwin,et al.  Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophrenia. , 1997, The American journal of psychiatry.

[31]  S. Brudzyński,et al.  Release of Dopamine in the Nucleus Accumbens Caused By Stimulation of the Subiculum in Freely Moving Rats , 1997, Brain Research Bulletin.

[32]  S. Hackley,et al.  The more or less startling effects of weak prestimulation - Revisted : Prepulse modulation of multicomponent blink reflexes , 1997 .

[33]  R. J. Meijer,et al.  Collateral projections from the rat hippocampal formation to the lateral and medial prefrontal cortex , 1997, Hippocampus.

[34]  R. Rodgers Animal models of 'anxiety': where next? , 1997, Behavioural pharmacology.

[35]  M. Dawson,et al.  The psychological significance of human startle eyeblink modification: a review , 1998, Biological Psychology.

[36]  M. Geyer,et al.  Multiple Limbic Regions Mediate the Disruption of Prepulse Inhibition Produced in Rats by the Noncompetitive NMDA Antagonist Dizocilpine , 1998, The Journal of Neuroscience.

[37]  H. Schnitzler,et al.  Induction of Fos-protein in the forebrain and disruption of sensorimotor gating following N-methyl-d-aspartate infusion into the ventral hippocampus of the rat , 1998, Neuroscience.

[38]  N. Alpert,et al.  Impaired recruitment of the hippocampus during conscious recollection in schizophrenia , 1998, Nature Neuroscience.

[39]  M. Bardgett,et al.  Haloperidol Blocks Increased Locomotor Activity Elicited by Carbachol Infusion Into the Ventral Hippocampal Formation , 1998, Pharmacology Biochemistry and Behavior.

[40]  M. Bardgett,et al.  Locomotor activity and accumbens Fos expression driven by ventral hippocampal stimulation require D1 and D2 receptors , 1999, Neuroscience.

[41]  Jeffrey A. Gray,et al.  Functions of the dopaminergic innervation of the nucleus accumbens , 1999, Psychobiology.

[42]  I. Weiner,et al.  Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. , 1999, Neuroreport.

[43]  C. Frith How Hallucinations Make Themselves Heard , 1999, Neuron.

[44]  Bernhard Lüscher,et al.  Decreased GABAA-receptor clustering results in enhanced anxiety and a bias for threat cues , 1999, Nature Neuroscience.

[45]  D L Braff,et al.  Sensorimotor gating and thought disturbance measured in close temporal proximity in schizophrenic patients. , 1999, Archives of general psychiatry.

[46]  M. Koch,et al.  Picrotoxin in the medial prefrontal cortex impairs sensorimotor gating in rats: reversal by haloperidol , 1999, Psychopharmacology.

[47]  N. Swerdlow,et al.  Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. , 1999, The American journal of psychiatry.

[48]  R. Wise,et al.  Injections of N‐methyl‐D‐aspartate into the ventral hippocampus increase extracellular dopamine in the ventral tegmental area and nucleus accumbens , 1999, Synapse.

[49]  M. Koch,et al.  Lesions of the rat piriform cortex prevent long-lasting sensorimotor gating deficits induced by stimulation of the ventral hippocampus , 1999, Neuroscience Letters.

[50]  M. Koch,et al.  The neurobiology of startle , 1999, Progress in Neurobiology.

[51]  J. Rawlins,et al.  Dissociating context and space within the hippocampus: effects of complete, dorsal, and ventral excitotoxic hippocampal lesions on conditioned freezing and spatial learning. , 1999, Behavioral neuroscience.

[52]  I. Weiner,et al.  The effects of hippocampal and fimbria-fornix lesions on prepulse inhibition. , 1999, Behavioral neuroscience.

[53]  W. Singer,et al.  Activation of Heschl’s Gyrus during Auditory Hallucinations , 1999, Neuron.

[54]  E. Keverne GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses , 1999, Brain Research Bulletin.

[55]  T. Rülicke,et al.  Molecular and neuronal substrate for the selective attenuation of anxiety. , 2000, Science.

[56]  Anthony A Grace,et al.  Gating of information flow within the limbic system and the pathophysiology of schizophrenia , 2000, Brain Research Reviews.

[57]  J. Feldon,et al.  Microinfusion of the non-competitive N-methyl-d-aspartate receptor antagonist MK-801 (dizocilpine) into the dorsal hippocampus of Wistar rats does not affect latent inhibition and prepulse inhibition, but increases startle reaction and locomotor activity , 2000, Neuroscience.

[58]  T. Sharma,et al.  Prepulse inhibition of the startle response in men with schizophrenia: effects of age of onset of illness, symptoms, and medication. , 2000, Archives of general psychiatry.

[59]  R. Murray,et al.  Mapping auditory hallucinations in schizophrenia using functional magnetic resonance imaging. , 2000, Archives of general psychiatry.

[60]  F. Benes,et al.  Emerging principles of altered neural circuitry in schizophrenia , 2000, Brain Research Reviews.

[61]  N. Swerdlow,et al.  Hippocampal lesions enhance startle gating-disruptive effects of apomorphine in rats: a parametric assessment , 2000, Neuroscience.

[62]  J. Feldon,et al.  Blockade of Latent Inhibition Following Pharmacological Increase or Decrease of GABAA Transmission , 2000, Pharmacology Biochemistry and Behavior.

[63]  J. Rotrosen,et al.  Impaired prepulse inhibition of acoustic startle in schizophrenia , 2000, Biological Psychiatry.

[64]  J. Feldon,et al.  Effects of MK801 and neuroleptics on prepulse inhibition: re-examination in two strains of rats , 2000, Pharmacology Biochemistry and Behavior.

[65]  A. Hamm,et al.  Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients , 2000, Biological Psychiatry.

[66]  N. Swerdlow,et al.  Distributed neurodegenerative changes 2–28 days after ventral hippocampal excitotoxic lesions in rats , 2000, Brain Research.

[67]  N. Swerdlow,et al.  Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. , 2000, Behavioural pharmacology.

[68]  R. Wise,et al.  Chemical Stimulation of the Ventral Hippocampus Elevates Nucleus Accumbens Dopamine by Activating Dopaminergic Neurons of the Ventral Tegmental Area , 2000, The Journal of Neuroscience.

[69]  A. Ylinen,et al.  Reciprocal Connections between the Amygdala and the Hippocampal Formation, Perirhinal Cortex, and Postrhinal Cortex in Rat: A Review , 2000, Annals of the New York Academy of Sciences.

[70]  J. Feldon,et al.  Hyperactivity and disruption of prepulse inhibition induced by N-methyl-d-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine , 2001, Neuroscience.

[71]  J. Feldon,et al.  The ventral hippocampus and fear conditioning in rats , 2001, Experimental Brain Research.

[72]  J. Jolles,et al.  The Neuropsychology of Schizophrenia , 2019 .

[73]  N. Swerdlow,et al.  Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats , 1995, Psychopharmacology.